创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

杜晗, 吴羿霏, 杜新. 人工智能在新药研发中的应用进展[J]. 药学进展, 2022, 46(11): 875-附页2. DOI: 10.20053/j.issn1001-5094.2022.11.009
引用本文: 杜晗, 吴羿霏, 杜新. 人工智能在新药研发中的应用进展[J]. 药学进展, 2022, 46(11): 875-附页2. DOI: 10.20053/j.issn1001-5094.2022.11.009
DU Han, WU Yifei, DU Xin. Advances in Application of Artificial Intelligence in New Drug Research and Development[J]. Progress in Pharmaceutical Sciences, 2022, 46(11): 875-附页2. DOI: 10.20053/j.issn1001-5094.2022.11.009
Citation: DU Han, WU Yifei, DU Xin. Advances in Application of Artificial Intelligence in New Drug Research and Development[J]. Progress in Pharmaceutical Sciences, 2022, 46(11): 875-附页2. DOI: 10.20053/j.issn1001-5094.2022.11.009

人工智能在新药研发中的应用进展

Advances in Application of Artificial Intelligence in New Drug Research and Development

  • 摘要: 近年来,人工智能技术快速迭代,为生物制药行业的高质量发展带来了新机遇。其作为新一代信息技术,将成为推动经济发展,助力疾病预防与诊疗,以及创新药物与医疗器械研发应用的核心驱动力之一。从药物设计、化学合成、药物再利用、多重药理学和药物筛选这5个方面综述了人工智能在新药研发中的应用进展,介绍相关成功案例,并分析了现阶段人工智能应用于新药研发所面临的挑战。

     

    Abstract: In recent years, the rapid iteration of artificial intelligence (AI) technique has brought new opportunities for the high-quality development of biopharmaceutical industry. As new generation of information technology, AI will become one of the core driving forces for economic development, disease prevention, diagnosis, and treatment, as well as the R&D and application of innovative drugs and medical devices. This article has reviewed the application progress of AI in new drug R&D from five aspects:drug design, chemical synthesis, drug reuse, polypharmacology, and drug screening. The article also has introduced the successful cases, and analyzed the current challenges in the application of AI in new drug R&D.

     

/

返回文章
返回